Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-24 @ 4:40 PM
NCT ID:
NCT02672566
Eligibility Criteria:
Inclusion Criteria:
* Patient over 18 years being at a gestational age ≥ 22 and \<34 weeks of gestation with vascular fetal growth retardation defined according CNGOF
* Ultrasound Estimated fetal weight below the 10th percentile
* Clinical and ultrasound findings suggesting pathologically impaired growth or diminished foetal well-being
* Clinical and ultrasound findings suggesting placental insufficiency
* Precise dating of pregnancy with an ultrasound between 11 + 0 and 13 + 6 weeks of gestation
* Written informed consent
Exclusion Criteria:
* multiple pregnancy or identified cause of IUGR (intra-uterine growth retardation)
* Patient with an immediate indication of fetal extraction
* Women with a history of venous thromboembolism or already treated with anti-coagulant
* Women with a contraindication to enoxaparin treatment at prophylactic doses
* Patient refusing to participate or unable to consent
* Patient with less than 80,000 platelets / mm 3 with the initial assessment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02672566
Study Brief:
Protocol Section:
NCT02672566